Pharmafile Logo
Pharmafocus logo
Advanced Search

MSD

Showing 15 posts of 247 posts found.

msd

MSD teams up with Harvard to develop new leukaemia treatments

March 24, 2016
Medical Communications, Research and Development AML, Harvard, MSD, leukaemia

MSD has entered a new collaboration with Harvard University aimed at developing innovative new small-molecule therapeutics for leukaemia and other …

News
sovaldi-web

Federal jury rules in MSD’s favour in Gilead blockbuster hepatitis C drug dispute

March 23, 2016
Medical Communications, Research and Development Gilead, MSD, blockbuster, federal court, federal jury, hit, patents, sales, sales hit, sofosbuvir, sovaldi

Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …

News
msd_sanat_chattopadhyay_

New manufacturing boss for MSD

March 10, 2016
Manufacturing and Production, Medical Communications MSD, manufacturing

MSD has appointed Sanat Chattopadhyay president of the Merck Manufacturing Division (MMD) and an executive vice president of the company. …

Appointment
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016
Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …

News
sanofi_pasteur_msd

Sanofi Pasteur and MSD end European vaccines partnership

March 8, 2016
Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines

Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …

News
gardasil_9

CHMP recommends Sanofi’s two-dose schedule HPV vaccine

March 3, 2016
Research and Development HPV vaccine, MSD, Sanofi Pasteur

Sanofi Pasteur’s and MSD’s vaccine against human papillomavirus (HPV), Gardasil 9, has received a positive opinion from the European Medicine …

News
msd

MHRA approves new indication for MSD’s Ezetrol

February 26, 2016
Medical Communications, Research and Development, Sales and Marketing MHRA, MSD, NICE, ezetrol

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new indication for MSD’s Ezetrol (ezetimibe), making it …

News
gilead-sciences

FDA approves Gilead’s Harvoni in two new indications

February 18, 2016
Research and Development Gilead Sciences, MSD, harvoni, hepatitis C

The hepatitis C treatment battle had its latest development yesterday, with the FDA awarding Gilead Science’s market-leading drug Harvoni (ledipasvir/sofosbuvir) …

News
msd

MSD’s Zepatier approval could spell end of Gilead’s Hep C dominance, says analyst

February 10, 2016
Sales and Marketing AbbVie, Drug pricing, Gilead Sciences, MSD, Solvadi, Viekira Pak, harvoni, hepatitis C

The introduction of MSDs’ recently FDA-approved drug Zepatier (elbasvir/grazoprevir) to the hepatitis C treatment space will shake up a market …

News
Merck image

Revenues down at MSD

February 4, 2016
Sales and Marketing MSD, financial performance, profits, revenue, sales

MSD (Merck, Sharpe and Dohme) reported a mixed bag of financial figures today, as the company announced full-year 2015 revenues …

News
Merck image

MSD gets FDA approval for hepatitis C drug Zepatier

January 29, 2016
Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C

The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …

News
GAVI logo

MSD and GAVI agree Ebola vaccine deal

January 20, 2016
Manufacturing and Production, Research and Development Ebola, GAVI, MSD, WHO

MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof  an Ebola virus vaccine, to …

News
Merck MSD

MSD sues German Merck for using name in US

January 15, 2016
Medical Communications, Sales and Marketing MSD, Merck

MSD says it is filing a lawsuit against the German company Merck “regarding their improper use of the name ‘Merck’ …

News
Keytruda image

BioLineRx to test lead candidate with MSD’s Keytruda in pancreatic cancer

January 13, 2016
Research and Development MSD, immunotherapy, keytruda, pembrolizumab

Israeli biopharma company BioLineRx has announced a collaboration with MSD on a Phase II study investigating its lead oncology candidate, …

News
MSD logo

MSD to acquire Scottish firm IOmet Pharma

January 12, 2016
Research and Development, Sales and Marketing IOMet Pharma, MSD, Merck, Scotland, acquisitions, immuno-oncology, mergers, oncology

US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026